Bath & Body Works (NYSE:BBWI) Releases Q1 2026 Earnings Guidance

Bath & Body Works (NYSE:BBWI) updated its first quarter 2026 earnings guidance on Wednesday. The company provided EPS guidance of 0.240-0.300 for the period, compared to the consensus EPS estimate of 1.170. The company issued revenue guidance of -. Bath & Body Works also updated its FY 2026 guidance to 2.400-2.650 EPS.

Bath & Body Works Stock Performance

BBWI stock opened at $23.23 on Wednesday. The firm has a fifty day moving average price of $22.25 and a 200 day moving average price of $23.59. The firm has a market cap of $4.76 billion, a PE ratio of 7.15, a price-to-earnings-growth ratio of 0.97 and a beta of 1.48. Bath & Body Works has a fifty-two week low of $14.27 and a fifty-two week high of $35.21.

Bath & Body Works (NYSE:BBWI) last released its quarterly earnings data on Wednesday, March 4th. The company reported $2.05 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.76 by $0.29. The company had revenue of $2.72 billion during the quarter, compared to analysts’ expectations of $2.59 billion. Bath & Body Works had a net margin of 9.50% and a negative return on equity of 47.35%. The firm’s quarterly revenue was down 2.3% on a year-over-year basis. During the same period in the previous year, the company earned $2.09 EPS. Bath & Body Works has set its Q1 2026 guidance at 0.240-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. On average, equities analysts predict that Bath & Body Works will post 3.3 EPS for the current year.

Bath & Body Works Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, March 6th. Stockholders of record on Friday, February 20th will be given a $0.20 dividend. The ex-dividend date is Friday, February 20th. This represents a $0.80 dividend on an annualized basis and a dividend yield of 3.4%. Bath & Body Works’s payout ratio is 24.62%.

Analyst Upgrades and Downgrades

BBWI has been the topic of a number of research reports. UBS Group raised their target price on shares of Bath & Body Works from $21.00 to $22.00 and gave the stock a “neutral” rating in a research note on Monday, February 23rd. Jefferies Financial Group started coverage on shares of Bath & Body Works in a research note on Wednesday, January 14th. They issued a “hold” rating and a $24.00 price target for the company. Weiss Ratings restated a “hold (c-)” rating on shares of Bath & Body Works in a research note on Wednesday, January 21st. Barclays lifted their target price on Bath & Body Works from $20.00 to $21.00 and gave the stock an “equal weight” rating in a research report on Monday. Finally, JPMorgan Chase & Co. decreased their price objective on Bath & Body Works from $26.00 to $15.00 and set a “neutral” rating for the company in a research report on Thursday, November 20th. Three equities research analysts have rated the stock with a Buy rating and fourteen have issued a Hold rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $23.86.

Key Stories Impacting Bath & Body Works

Here are the key news stories impacting Bath & Body Works this week:

• Positive Sentiment: Q4 results beat expectations — Bath & Body Works reported adjusted EPS of $2.05 and revenue of $2.72B, both topping street estimates, which drove an early positive reaction in premarket trading. Stronger-than-expected quarterly execution supports near-term earnings visibility. Bath & Body Works (BBWI) Q4 Earnings and Revenues Surpass Estimates
• Positive Sentiment: Management says strategic pivot is progressing — the company highlighted progress on its “Consumer First” formula (innovation, brand elevation, marketplace expansion), which investors may view as constructive for medium‑term margin and category focus. Company Press Release
• Neutral Sentiment: Analyst price target moves — Deutsche Bank and Barclays nudged price targets/rating levels (small adjustments, both maintain non‑buy stances), which suggests analysts are cautious despite the beat. Deutsche Bank Adjusts PT
• Neutral Sentiment: Earnings and slide materials available — company posted its press release and slide deck; useful for investors wanting detail on comps, margin drivers and channel performance. Slide Deck / Press Release
• Negative Sentiment: Guidance disappointed — FY2026 EPS guidance of $2.40–2.65 and Q1 guidance of $0.24–0.30 are below consensus (FY and Q1), reducing near‑term upside and tempering the positive surprise from the quarter. Guidance and Results
• Negative Sentiment: Company forecasts steeper annual sales decline — management flagged weaker demand for higher‑priced fragrance and candle items as consumers pull back, a drag on top‑line recovery. Reuters: Forecasts Steeper Sales Decline
• Negative Sentiment: Multiple securities‑class action notices — several law firms have filed or notified investors of class actions covering mid‑2024 to late‑2025 periods, creating potential legal overhang and headline risk. Deadlines for lead‑plaintiff motions are imminent. Levi & Korsinsky Notice
• Negative Sentiment: Institutional selling noted — a large stake was liquidated last quarter (Cooper Creek), which reduced an institutional position by roughly $129M and can add downward pressure on shares. Fool: Stake Liquidated

Institutional Investors Weigh In On Bath & Body Works

Several hedge funds have recently made changes to their positions in BBWI. Global Retirement Partners LLC acquired a new position in Bath & Body Works during the 4th quarter worth about $31,000. Geneos Wealth Management Inc. boosted its stake in shares of Bath & Body Works by 217.7% during the 1st quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock worth $35,000 after buying an additional 801 shares during the last quarter. Parallel Advisors LLC raised its position in Bath & Body Works by 42.6% during the fourth quarter. Parallel Advisors LLC now owns 1,897 shares of the company’s stock worth $38,000 after acquiring an additional 567 shares in the last quarter. Danske Bank A S acquired a new position in shares of Bath & Body Works during the 3rd quarter worth approximately $39,000. Finally, Advisory Services Network LLC bought a new position in Bath & Body Works in the 3rd quarter valued at about $48,000. Hedge funds and other institutional investors own 95.14% of the company’s stock.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.